Diametric Capital »

Biosante Pharmaceuticals shares owned by Diametric Capital

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $911k 12k 76.90

More positions owned by Diametric Capital

Precigen (PGEN)
Bitmine Immersion Tecnologie Com New (BMNR)
Janone (ALTS)
Liquidia Corporation Com New (LQDA)
Fulgent Genetics (FLGT)
Golar Lng SHS (GLNG)
Penn National Gaming (PENN)
Wynn Resorts (WYNN)
Brinker International (EAT)
Forgent Power Solutions Com Shs Cl A (FPS)
Asp Isotopes (ASPI)
Telephone & Data Sys Com New (TDS)
Harrow Health (HROW)
Eton Pharmaceuticals (ETON)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Diametric Capital

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
State Street Corporation
Tang Capital Management
Deep Track Capital
Millennium Management
Dimensional Fund Advisors
UBS Group
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Nuveen
Vanguard Portfolio Management
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals